Which medication is commonly prescribed for the treatment of osteoporosis?

Alendronate is a bisphosphonate medication that is specifically indicated for the treatment of osteoporosis. It works by inhibiting osteoclast-mediated bone resorption, which helps to increase bone density and reduce the risk of fractures in patients with osteoporosis. This medication is often prescribed for postmenopausal women and individuals with other risk factors for osteoporosis.

In contrast, meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) primarily used to relieve pain and inflammation, not indicated for osteoporosis treatment. Prednisone is a corticosteroid that can lead to bone loss if used long-term, and while it may inadvertently be involved in osteoporosis management, it is not a specific treatment for the condition itself. Hydroxyurea is primarily used in the treatment of certain cancers and blood disorders and does not address osteoporosis. Therefore, the appropriateness of alendronate arises from its specific action in mitigating the effects of osteoporosis by strengthening bones.